The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index... Show more
FXH saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The 10-day RSI Indicator for FXH moved out of overbought territory on January 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on January 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXH as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
FXH moved below its 50-day moving average on January 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
FXH broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FXH advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .
Category Health
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GENIX | 15.22 | 0.19 | +1.26% |
| Gotham Enhanced Return Institutional | |||
| FSWFX | 76.65 | 0.48 | +0.63% |
| American Funds SMALLCAP World 529-F-2 | |||
| FSTSX | 18.48 | N/A | N/A |
| Fidelity Series International Sm Cap | |||
| MSAYX | 22.28 | -0.11 | -0.49% |
| Morgan Stanley Inst Asia Opp R6 | |||
| GOVIX | 24.63 | -0.27 | -1.08% |
| GMO Resources IV | |||
A.I.dvisor indicates that over the last year, FXH has been closely correlated with VHT. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if FXH jumps, then VHT could also see price increases.